TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Press release
Feb 22, 2021 13:11 JST
Source:
Eisai
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy
TOKYO, Feb 22, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received the 18th Corporate Philanthropy Award (FY 2020) of the Japan Philanthropic Association. The presentation ceremony was held on February 19, 2021 (Friday) at the GakushiKaikan (Chiyoda-ku, Tokyo).
The Corporate Philanthropy Award was founded in 2003 with the aim of commending companies for their activities for social contribution that organically and sustainably utilize their management resources (human resources, know-how, technology, information, etc.) in order to solve social issues, and of passing on a fair, warm and vibrant society to the next generation by broadly disseminating those social contribution activities to society.
The award was presented to Eisai for its corporate philosophy of human health care (hhc) and its activities to realize the hhc philosophy, evaluating "a corporate culture and purposeful activities where employees demonstrate their true value toward the realization of a society in which people can live happily."
Eisai's corporate philosophy is to give first thought to patients and their families, and increase the benefits that health care provides, and Eisai calls this philosophy the "human health care (hhc)" philosophy, in one word. In 2005, Eisai stipulated this philosophy as one of its Articles of Incorporation with the support of its shareholders. As an initiative to embody this hhc philosophy, Eisai recommends all officers and employees of the Eisai Group, including outside directors, to spend 1% of their business hours with patients and to engage in "socialization" to know their emotions. In addition, for developing and emerging countries, Eisai has continuously provided a treatment for lymphatic filariasis, which is one of the neglected tropical disease (NTDs), free of charge to endemic counties through the World Health Organization (WHO). Furthermore, Eisai has adopted the tiered-pricing model for its innovative new drugs, which sets multiple tiered prices according to the patient's income level and the insurance coverage that patients could afford. Thus, we are promoting various efforts to improve access to pharmaceutical products.
Award ceremony (left: Ms. Yoko Takahashi, director, the Japan Philanthropic Association, right: Keigo Kato, executive director, Knowledge Creation Dept., Eisai)
Eisai will make continuous efforts, based on the hhc philosophy, to further contribute to increasing the benefits of patients and their families around the world.
Source: Eisai
Sectors: BioTech
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease
March 05 2021 16:51 JST
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya
March 04 2021 08:12 JST
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
March 02 2021 08:06 JST
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090
February 22 2021 14:40 JST
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
February 15 2021 10:07 JST
Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea
February 01 2021 08:35 JST
Eisai Listed as a Global 100 Most Sustainable Corporation for the Fifth Time
January 26 2021 10:58 JST
Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
January 12 2021 11:37 JST
Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan
December 18 2020 12:09 JST
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR
December 17 2020 11:47 JST
More Press release >>
Latest Press Release
UREEQA Welcomes Dean Drever, a Sculptor Who Has Produced Multi-Million Dollar Works of Art
Mar 08, 2021 07:00 JST
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease
Mar 05, 2021 17:51 JST
MHI Group Presents "Best Innovation 2020" Awards for Activities that Contribute to Reducing Environmental Loads
Mar 05, 2021 09:30 JST
Billboard Hot 100 #1 Hit of the Year Band Member Partners with UREEQA
Mar 04, 2021 19:50 JST
Honda to Begin Sales of Legend with New Honda SENSING Elite
Mar 04, 2021 16:29 JST
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya
Mar 04, 2021 09:12 JST
Chiseikan Dojo in Kyoto Grand Opening Event: "When in danger, how can you best protect yourself?"
Mar 04, 2021 07:00 JST
Hitachi Developed the Hitachi Electronic Signature Service, to Eliminate Personal Seals with High Authenticity of Information by Blockchain Technology
Mar 03, 2021 11:48 JST
DENSO, KDDI Research 5G's use in Automated Driving to Achieve Safe and Secure Mobility
Mar 03, 2021 11:16 JST
Toyota Plans to Issue 'Woven Planet Bonds'
Mar 02, 2021 15:34 JST
Lockheed Martin and NEC Put AI to Work on Programs like NASA's Artemis Mission
Mar 02, 2021 14:03 JST
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
Mar 02, 2021 09:06 JST
Mitsubishi Power Commences Development of World's First Ammonia-fired 40MW Class Gas Turbine System
Mar 01, 2021 18:46 JST
MHI Machine Tool Develops Gear Shaping Machine for High-Precision Small-Module Gears Used in Robots
Mar 01, 2021 18:36 JST
Flying Finn Rovanpera Claims the Championship Lead in the Toyota Yaris WRC
Mar 01, 2021 10:46 JST
BYD to Help Kyoto Reach Japan's 2050 Carbon Neutral Goal
Feb 26, 2021 11:20 JST
Fujitsu and University of Toronto Researchers Develop Quantum-Inspired Technology to Optimize Radiation Treatment Plans for Brain Tumors and Other Diseases
Feb 26, 2021 10:59 JST
DENSO and Yamato Transport Develop D-mobico, Compact Mobile Refrigerator
Feb 25, 2021 19:28 JST
Mazda Production and Sales Results for January 2021
Feb 25, 2021 17:33 JST
Honda Reports Production, Sales and Export Results in January, 2021
Feb 25, 2021 15:27 JST
More Latest Release >>